Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017

G E van der Kraaij^{1

2

3}, D M W Balak⁴, C I Busard^{1

2}, O D van Cranenburgh^{1

5}, Y Chung³, R J B Driessen⁶, M de Groot⁷, E M G J de Jong^{6

8}, P M J H Kemperman^{1

9}, W J A de Kort¹⁰, S A Karsch³, A Lamberts^{3

11}, L L A Lecluse¹², P P M van Lümig⁶, S P Menting¹, E P Prens¹³, J M P A van den Reek⁶, M M B Seyger⁶, H B Thio¹³, W R Veldkamp^{3

8}, M Wakkee¹³, A Nast¹⁴, A Jacobs¹⁴, S Rosumeck¹⁴, P I Spuls Chair^{1

2}

Affiliations

¹ Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
² Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
³ Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands.
⁴ University Medical Centre Utrecht, Utrecht, the Netherlands.
⁵ Dutch Skin Foundation, Nieuwegein, the Netherlands.
⁶ Radboud University Medical Centre, Nijmegen, the Netherlands.
⁷ Antonius Hospital, Sneek/Emmeloord, the Netherlands.
⁸ Radboud University Nijmegen, the Netherlands.
⁹ Waterlandziekenhuis, Purmerend, the Netherlands.
¹⁰ Amphia Hospital, Breda, the Netherlands.
¹¹ University Medical Center Groningen, Groningen, the Netherlands.
¹² Bergman Clinics and U-clinic, Amsterdam, the Netherlands.
¹³ Erasmus Medical Centre, Rotterdam, the Netherlands.
¹⁴ Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

G E van der Kraaij et al. Br J Dermatol. 2019 Jan.

. 2019 Jan;180(1):31-42.

doi: 10.1111/bjd.17198.

¹ Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
² Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
³ Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands.
⁴ University Medical Centre Utrecht, Utrecht, the Netherlands.
⁵ Dutch Skin Foundation, Nieuwegein, the Netherlands.
⁶ Radboud University Medical Centre, Nijmegen, the Netherlands.
⁷ Antonius Hospital, Sneek/Emmeloord, the Netherlands.
⁸ Radboud University Nijmegen, the Netherlands.
⁹ Waterlandziekenhuis, Purmerend, the Netherlands.
¹⁰ Amphia Hospital, Breda, the Netherlands.
¹¹ University Medical Center Groningen, Groningen, the Netherlands.
¹² Bergman Clinics and U-clinic, Amsterdam, the Netherlands.
¹³ Erasmus Medical Centre, Rotterdam, the Netherlands.
¹⁴ Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Abstract

Linked Comment: https://doi.org/10.1111/bjd.17390.

Dutch guidelines for psoriasis treatment.
Ormerod AD. Ormerod AD. Br J Dermatol. 2019 Jan;180(1):11. doi: 10.1111/bjd.17390. Br J Dermatol. 2019. PMID: 30604544 No abstract available.

1. Nederlandse Vereniging voor Dermatologie en Venereologie. Richtlijn Psoriasis 2011. Available at: https://www.huidziekten.nl/richtlijnen/richtlijn-psoriasis-2011.pdf (last accessed 13 November 2018) (in Dutch).
1. Zweegers J, de Jong EM, Nijsten TE et al Summary of the Dutch S3‐guidelines on the treatment of psoriasis 2011. Dermatol Online J 2014; 20:1–113. - PubMed
1. Nast A GP, Ormerod AD, Saiag P et al European S3‐Guidelines on the systemic treatment of psoriasis vulgaris. 2015. J Eur Acad Dermatol Venereol 2015; 29:2277–94. - PubMed
1. Spuls PI, van der Kraaij GE, Chung Y et al Psoriasis Multidisciplinaire Evidence Based Richtlijn 2017. Available at: http://www.nvdv.nl/wp-content/uploads/2014/08/190218_voorlopig-definitie... (13 November 2018) (in Dutch).
1. Nast A, Jacobs A, Rosumeck S, Werner RN. Methods report: European S3‐guidelines on the systemic treatment of psoriasis vulgaris–update 2015–EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol 2015; 29:e1–22. - PubMed